1 week DVA Stock Down in Pre-Market Despite Q4 Earnings Beat, Margins Expand Zacks

Robust segmental revenues drive DaVita’s fourth-quarter 2024 performance despite a per-day decrease of the total U.S. dialysis treatments on a sequential basis.